Skip to main content
. Author manuscript; available in PMC: 2018 Apr 26.
Published in final edited form as: N Engl J Med. 2017 Oct 4;377(17):1630–1638. doi: 10.1056/NEJMoa1700554

Figure 4. Gadolinium Enhancement on MRI.

Figure 4

Shown are the results of assessments for gadolinium enhancement on MRI for each of the 17 patients at various time points after the infusion of the Lenti-D drug product. Gadolinium enhancement on reemergence after initial resolution was uniformly more diffuse than the enhancement seen at baseline but was still assessed as positive. Patient 2016 withdrew from the study at month 13. To review the MRIs, see Figure S5 in the Supplementary Appendix.